Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 626 - 650 of 831 in total
Investigational
GPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the immune response. The GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety of vaccines, has been shown to have good overall performance characteristics on safety and efficacy.
Investigational
Investigational
LM-609 (Vitaxin) is an artificial antibody that targets a protein on the surface of newly forming blood vessels, as well as on certain tumors. In addition to cancer, the protein has been implicated in bone destruction in rheumatoid arthritis and the inflammatory process in psoriasis.
Investigational
Allovectin-7 or allovectin-7(r) is a lipid complex that contains the DNA sequences encoding HLA-B7 and beta-2 microglobulin. It was discontinued after it failed to improve the objective response rate or overall survival versus first-line chemotherapy in malignant melanoma.
Investigational
Matched Description: … improve the objective response rate or overall survival versus first-line chemotherapy in malignant melanoma
Ferric pyrophosphate is an iron replacement product. Free iron presents several side effects as it can catalyze free radical formation and lipid peroxidation as well as the presence of interactions of iron in plasma. The ferric ion is strongly complexed by pyrophosphate. It presents an increasing interest as this insoluble...
Experimental
Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of candesartan cilexetil.
Experimental
Matched Categories: … Angiotensin II receptor antagonists ... Angiotensin II Type 2 Receptor Blockers ... Angiotensin II receptor blockers (ARBs), plain ... Angiotensin II receptor blockers (ARBs) and diuretics ... Angiotensin II receptor blockers (ARBs) and calcium channel blockers …
Alethine is studied in the treatment of cancer. It belongs to a family of chemicals called disulfides. It is a low molecular weight disulfide that has been shown to exhibit in vivo antitumor activity in murine myeloma and melanoma models.
Investigational
Matched Description: … molecular weight disulfide that has been shown to exhibit in vivo antitumor activity in murine myeloma and melanoma
Investigational
Silmitasertib is under investigation in clinical trial NCT03904862 (Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery).
Investigational
Matched Categories: … Casein Kinase II, antagonists & inhibitors …
XR11576 (MLN576) is a novel monophenazine with a mechanism of action that includes interaction with both topoisomerase (Topo) I and II.
Investigational
Matched Description: … monophenazine with a mechanism of action that includes interaction with both topoisomerase (Topo) I and II
Matched Categories: … Topoisomerase II Inhibitors …
Fluocortin has been studied as a corticosteroid for treatment of dermatitis and eczema Spain .
Experimental
Matched Categories: … Corticosteroids, Moderately Potent (Group II) …
Homidium is a group II compound with trypanocidal effects.
Investigational
Matched Description: … Homidium is a group II compound with trypanocidal effects.[A253017] …
Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.
Investigational
Matched Description: … Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II. …
AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways implicated in cancer cell proliferation and survival. AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including melanoma, pancreatic, colon, lung, and breast cancers.
Investigational
Matched Description: … -8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including melanoma
Preimplantation factor is under investigation in clinical trial NCT03593460 (Phase II Autoimmune Hepatitis).
Investigational
Matched Description: … Preimplantation factor is under investigation in clinical trial NCT03593460 (Phase II Autoimmune Hepatitis …
Granotapide has been used in trials studying the treatment of Type II Diabetes Mellitus.
Investigational
Matched Description: … Granotapide has been used in trials studying the treatment of Type II Diabetes Mellitus. …
VB2-011 is an antibody developed as an anti-cancer treatment. According to some preclinical studies, it has a potential to inhibit tumour growth in various cancers including lymphoma and melanoma. This drug includes the parent IgM (H11 IgM) and a recombinant IgG version (H11 IgG).
Investigational
Matched Description: … preclinical studies, it has a potential to inhibit tumour growth in various cancers including lymphoma and melanoma
SP1049C is a novel anthracycline chemotherapeutic agent containing doxorubicin and two nonionic pluronic block copolymers. It is designed to overcome drug resistance in a number of cancers. It has successfully completed Phase 1 trials. Phase 2 results are currently under final review. Preliminary data, in its first clinically tested indication,...
Investigational
Experimental
Vet approved
An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.
Investigational
Nutraceutical
Matched Mixtures name: … Aminosyn II ... Aminosyn II ... Aminosyn II
Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It...
Nutraceutical
Matched Mixtures name: … Aminosyn II ... Aminosyn II ... Aminosyn II
Experimental
Investigational
Displaying drugs 626 - 650 of 831 in total